SCHEMBL10942829

SCHEMBL10942829

C=C(C(=O)O)C(=O)C(C)O

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.45
TET2 Q6N021 4/20 0.32
TET3 O43151 1/20 0.32
TET1 Q8NFU7 1/20 0.32
SLC7A5 Q01650 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13342682 0.78 TP53 (0.38) TP53
SCHEMBL13828474 0.77
SCHEMBL6135493 0.76 TDP1 (0.41) TP53SLC7A5
SCHEMBL1644613 0.76
SCHEMBL11025750 0.71 TP53 (0.57) TP53
SCHEMBL7116467 0.71
SCHEMBL31173032 0.71
SCHEMBL16662 0.71
SCHEMBL4282536 0.71
Ethylene SCHEMBL7184474 0.69 TP53 (0.47) TP53TET2TET3TET1SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100435717-C Endoscopic accessory device CONTURA SA (DK) 2008-11-26 CN claimed
CN-1809310-A Endoscopic attachment device CONTURA SA (CH) 2006-07-26 CN claimed
CN-103505718-B Compstatin and analogs thereof for eye disorders 阿佩利斯制药公司 2018-11-23 CN disclosed
CN-105582523-A Compstatin and analogs thereof for eye disorders POTENTIA PHARMACEUTICALS INC 2016-05-18 CN disclosed
CN-101325963-B Compstatin and analogs thereof for ocular disorders POTENTIA PHARMACEUTICALS, INC. (US) 2016-01-27 CN disclosed
CN-103830282-A Metabolized conditioned growth medium and methods of use ALLERGAN INC 2014-06-04 CN disclosed
CN-103830383-A Metabolized conditioned growth medium and methods of use ALLERGAN INC 2014-06-04 CN disclosed
CN-103816108-A Metabolized conditioned growth medium and methods of use ALLERGAN INC 2014-05-28 CN disclosed
CN-103816188-A Metabolized conditioned growth medium and methods of use ALLERGAN INC 2014-05-28 CN disclosed
CN-103820336-A Metabolized conditioned growth medium and methods of use ALLERGAN INC 2014-05-28 CN disclosed
CN-103635198-A Metabolized conditioned growth medium and methods of use ALLERGAN INC 2014-03-12 CN disclosed
CN-103505718-A Compstatin and analogs thereof for eye disorders POTENTIA PHARMACEUTICALS INC 2014-01-15 CN disclosed
CN-101325963-A Compstatin and analogs thereof for ocular disorders POTENTIA PHARMACEUTICALS INC (US) 2008-12-17 CN disclosed
CN-100435717-C Endoscopic accessory device CONTURA SA (DK) 2008-11-26 CN disclosed
CN-1809310-A Endoscopic attachment device CONTURA SA (CH) 2006-07-26 CN disclosed
CN-1672630-A Apparatus and method for marking tissue ETHICON ENDO SURGERY INC (US) 2005-09-28 CN disclosed
CN-1198628-C Conditioned cell culture medium compositions and method of use SKIN MEDICAL INC (US) 2005-04-27 CN disclosed
CN-1376067-A Conditioned cell culture medium compositions and method of use ADVANCED TISSUE SICENCES INC (US) 2002-10-23 CN disclosed
EP-0041205-B1 PROCESS FOR THE MANUFACTURING OF FILTER MATERIALS MD-Papierfabrik Pasing Nicolaus & Co. (DE) 1985-12-11 EP disclosed
EP-0041205-A1 Process for the manufacturing of filter materials MD-Papierfabrik Pasing Nicolaus & Co. (DE) 1981-12-09 EP disclosed